These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
287 related articles for article (PubMed ID: 7641210)
1. Estrogen promotes chemotherapeutic drug resistance by a mechanism involving Bcl-2 proto-oncogene expression in human breast cancer cells. Teixeira C; Reed JC; Pratt MA Cancer Res; 1995 Sep; 55(17):3902-7. PubMed ID: 7641210 [TBL] [Abstract][Full Text] [Related]
2. Altered expression of estrogen-regulated genes in a tamoxifen-resistant and ICI 164,384 and ICI 182,780 sensitive human breast cancer cell line, MCF-7/TAMR-1. Lykkesfeldt AE; Madsen MW; Briand P Cancer Res; 1994 Mar; 54(6):1587-95. PubMed ID: 8137264 [TBL] [Abstract][Full Text] [Related]
3. Antiestrogens are pro-apoptotic in normal human breast epithelial cells. Somaï S; Chaouat M; Jacob D; Perrot JY; Rostène W; Forgez P; Gompel A Int J Cancer; 2003 Jul; 105(5):607-12. PubMed ID: 12740907 [TBL] [Abstract][Full Text] [Related]
4. Down-regulation of apoptosis-related bcl-2 but not bcl-xL or bax proteins in multidrug-resistant MCF-7/Adr human breast cancer cells. Ogretmen B; Safa AR Int J Cancer; 1996 Sep; 67(5):608-14. PubMed ID: 8782646 [TBL] [Abstract][Full Text] [Related]
5. Differential sensitivity of MCF-7 and LCC2 cells, to multiple growth inhibitory agents: possible relation to high bcl-2/bax ratio? Lilling G; Hacohen H; Nordenberg J; Livnat T; Rotter V; Sidi Y Cancer Lett; 2000 Dec; 161(1):27-34. PubMed ID: 11078910 [TBL] [Abstract][Full Text] [Related]
6. Different expression patterns of Bcl-2 family genes in breast cancer by estrogen receptor status with special reference to pro-apoptotic Bak gene. Eguchi H; Suga K; Saji H; Toi M; Nakachi K; Hayashi SI Cell Death Differ; 2000 May; 7(5):439-46. PubMed ID: 10800077 [TBL] [Abstract][Full Text] [Related]
8. Regulation of BAX and BCL-2 expression in breast cancer cells by chemotherapy. Gibson LF; Fortney J; Magro G; Ericson SG; Lynch JP; Landreth KS Breast Cancer Res Treat; 1999 May; 55(2):107-17. PubMed ID: 10481938 [TBL] [Abstract][Full Text] [Related]
9. Estrogen increases intracellular p26Bcl-2 to p21Bax ratios and inhibits taxol-induced apoptosis of human breast cancer MCF-7 cells. Huang Y; Ray S; Reed JC; Ibrado AM; Tang C; Nawabi A; Bhalla K Breast Cancer Res Treat; 1997 Jan; 42(1):73-81. PubMed ID: 9116321 [TBL] [Abstract][Full Text] [Related]
10. Differential effects of chemotherapeutic agents on the Bcl-2/Bax apoptosis pathway in human breast cancer cell line MCF-7. Leung LK; Wang TT Breast Cancer Res Treat; 1999 May; 55(1):73-83. PubMed ID: 10472781 [TBL] [Abstract][Full Text] [Related]
11. Buthionine sulfoximine sensitizes antihormone-resistant human breast cancer cells to estrogen-induced apoptosis. Lewis-Wambi JS; Kim HR; Wambi C; Patel R; Pyle JR; Klein-Szanto AJ; Jordan VC Breast Cancer Res; 2008; 10(6):R104. PubMed ID: 19061505 [TBL] [Abstract][Full Text] [Related]
12. Models of estrogen receptor regulation by estrogens and antiestrogens in breast cancer cell lines. Pink JJ; Jordan VC Cancer Res; 1996 May; 56(10):2321-30. PubMed ID: 8625307 [TBL] [Abstract][Full Text] [Related]
13. Upregulation of miR-195 increases the sensitivity of breast cancer cells to Adriamycin treatment through inhibition of Raf-1. Yang G; Wu D; Zhu J; Jiang O; Shi Q; Tian J; Weng Y Oncol Rep; 2013 Aug; 30(2):877-89. PubMed ID: 23760062 [TBL] [Abstract][Full Text] [Related]
14. Alterations in estrogen signalling pathways upon acquisition of anthracycline resistance in breast tumor cells. Chewchuk S; Guo B; Parissenti AM PLoS One; 2017; 12(2):e0172244. PubMed ID: 28196134 [TBL] [Abstract][Full Text] [Related]
15. Association of interferon regulatory factor-1, nucleophosmin, nuclear factor-kappaB, and cyclic AMP response element binding with acquired resistance to Faslodex (ICI 182,780). Gu Z; Lee RY; Skaar TC; Bouker KB; Welch JN; Lu J; Liu A; Zhu Y; Davis N; Leonessa F; Brünner N; Wang Y; Clarke R Cancer Res; 2002 Jun; 62(12):3428-37. PubMed ID: 12067985 [TBL] [Abstract][Full Text] [Related]
16. Characterization of a receptor-negative, hormone-nonresponsive clone derived from a T47D human breast cancer cell line kept under estrogen-free conditions. Murphy CS; Pink JJ; Jordan VC Cancer Res; 1990 Nov; 50(22):7285-92. PubMed ID: 2224859 [TBL] [Abstract][Full Text] [Related]
17. C-myc gene expression alone is sufficient to confer resistance to antiestrogen in human breast cancer cells. Venditti M; Iwasiow B; Orr FW; Shiu RP Int J Cancer; 2002 May; 99(1):35-42. PubMed ID: 11948489 [TBL] [Abstract][Full Text] [Related]
18. Antagonism between estradiol and progestin on Bcl-2 expression in breast-cancer cells. Kandouz M; Siromachkova M; Jacob D; Chretien Marquet B; Therwath A; Gompel A Int J Cancer; 1996 Sep; 68(1):120-5. PubMed ID: 8895551 [TBL] [Abstract][Full Text] [Related]
19. Resistance to different antiestrogens is caused by different multi-factorial changes and is associated with reduced expression of IGF receptor Ialpha. Brockdorff BL; Heiberg I; Lykkesfeldt AE Endocr Relat Cancer; 2003 Dec; 10(4):579-90. PubMed ID: 14713268 [TBL] [Abstract][Full Text] [Related]
20. Hormonal modulation of HER-2/neu protooncogene messenger ribonucleic acid and p185 protein expression in human breast cancer cell lines. Read LD; Keith D; Slamon DJ; Katzenellenbogen BS Cancer Res; 1990 Jul; 50(13):3947-51. PubMed ID: 1972345 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]